Kunming Longjin Pharmaceutical Co Ltd (002750) - Cash Flow Conversion Efficiency

Latest as of September 2023: -0.011x

Based on the latest financial reports, Kunming Longjin Pharmaceutical Co Ltd (002750) has a cash flow conversion efficiency ratio of -0.011x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-6.69 Million ≈ $-978.60K USD) by net assets (CN¥582.16 Million ≈ $85.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Kunming Longjin Pharmaceutical Co Ltd (002750) total market value for the company's overall valuation and market capitalisation.

Kunming Longjin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kunming Longjin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kunming Longjin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kunming Longjin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Kunming Longjin Pharmaceutical Co Ltd (002750) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Rekah Pharmaceutical Industry Ltd TA:REKA	0.099x
Jinli Group Holdings Ltd TW:8429	0.000x
JAS Asset PCL BK:J	0.016x
Generations Bancorp NY Inc NASDAQ:GBNY	0.047x
Hudson Global Inc NASDAQ:HSON	0.003x
IMCO Industries Ltd TA:IMCO	0.207x
HP Adhesives Limited NSE:HPAL	0.058x
Legacy Iron Ore Ltd AU:LCY	0.095x

Annual Cash Flow Conversion Efficiency for Kunming Longjin Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2024. View today's stock price for Kunming Longjin Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥494.21 Million ≈ $72.32 Million	CN¥-34.24 Million ≈ $-5.01 Million	-0.069x	+4.52%
2023-12-31	CN¥541.13 Million ≈ $79.18 Million	CN¥-39.26 Million ≈ $-5.75 Million	-0.073x	-203.80%
2022-12-31	CN¥604.77 Million ≈ $88.50 Million	CN¥-14.44 Million ≈ $-2.11 Million	-0.024x	-9.42%
2021-12-31	CN¥678.29 Million ≈ $99.26 Million	CN¥-14.80 Million ≈ $-2.17 Million	-0.022x	-126.96%
2020-12-31	CN¥704.71 Million ≈ $103.12 Million	CN¥-6.78 Million ≈ $-991.68K	-0.010x	-258.38%
2019-12-31	CN¥665.89 Million ≈ $97.44 Million	CN¥4.04 Million ≈ $591.66K	0.006x	-87.44%
2018-12-31	CN¥655.93 Million ≈ $95.98 Million	CN¥31.70 Million ≈ $4.64 Million	0.048x	-46.27%
2017-12-31	CN¥645.54 Million ≈ $94.46 Million	CN¥58.06 Million ≈ $8.50 Million	0.090x	-42.15%
2016-12-31	CN¥670.46 Million ≈ $98.11 Million	CN¥104.24 Million ≈ $15.25 Million	0.155x	+32.78%
2015-12-31	CN¥599.41 Million ≈ $87.71 Million	CN¥70.19 Million ≈ $10.27 Million	0.117x	-52.34%
2014-12-31	CN¥285.57 Million ≈ $41.79 Million	CN¥70.16 Million ≈ $10.27 Million	0.246x	-30.30%
2013-12-31	CN¥302.00 Million ≈ $44.19 Million	CN¥106.46 Million ≈ $15.58 Million	0.353x	-12.24%
2012-12-31	CN¥226.94 Million ≈ $33.21 Million	CN¥91.16 Million ≈ $13.34 Million	0.402x	-1.16%
2011-12-31	CN¥186.74 Million ≈ $27.33 Million	CN¥75.90 Million ≈ $11.11 Million	0.406x	--

About Kunming Longjin Pharmaceutical Co Ltd

SHE:002750 China Drug Manufacturers - Specialty & Generic

Market Cap

$34.58 Million

CN¥236.29 Million CNY

Market Cap Rank

#23380 Global

#4713 in China

Share Price

CN¥0.59

Change (1 day)

+0.00%

52-Week Range

CN¥0.59 - CN¥0.59

All Time High

CN¥25.99